Literature DB >> 18850616

Enantiocomplementary enzymes: classification, molecular basis for their enantiopreference, and prospects for mirror-image biotransformations.

Paul F Mugford1, Ulrike G Wagner, Yun Jiang, Kurt Faber, Romas J Kazlauskas.   

Abstract

One often-cited weakness of biocatalysis is the lack of mirror-image enzymes for the formation of either enantiomer of a product in asymmetric synthesis. Enantiocomplementary enzymes exist as the solution to this problem in nature. These enzyme pairs, which catalyze the same reaction but favor opposite enantiomers, are not mirror-image molecules; however, they contain active sites that are functionally mirror images of one another. To create mirror-image active sites, nature can change the location of the binding site and/or the location of key catalytic groups. In this Minireview, X-ray crystal structures of enantiocomplementary enzymes are surveyed and classified into four groups according to how the mirror-image active sites are formed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18850616     DOI: 10.1002/anie.200705159

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  17 in total

1.  Rational assignment of key motifs for function guides in silico enzyme identification.

Authors:  Matthias Höhne; Sebastian Schätzle; Helge Jochens; Karen Robins; Uwe T Bornscheuer
Journal:  Nat Chem Biol       Date:  2010-09-26       Impact factor: 15.040

2.  Exploring the enantioselective mechanism of halohydrin dehalogenase from Agrobacterium radiobacter AD1 by iterative saturation mutagenesis.

Authors:  Chao Guo; Yanpu Chen; Yu Zheng; Wei Zhang; Yunwen Tao; Juan Feng; Lixia Tang
Journal:  Appl Environ Microbiol       Date:  2015-02-13       Impact factor: 4.792

3.  Chemoenzymatic synthesis of differentially protected 3-deoxysugars.

Authors:  Dennis G Gillingham; Pierre Stallforth; Alexander Adibekian; Peter H Seeberger; Donald Hilvert
Journal:  Nat Chem       Date:  2010-01-17       Impact factor: 24.427

4.  Gram-Scale Synthesis of Chiral Cyclopropane-Containing Drugs and Drug Precursors with Engineered Myoglobin Catalysts Featuring Complementary Stereoselectivity.

Authors:  Priyanka Bajaj; Gopeekrishnan Sreenilayam; Vikas Tyagi; Rudi Fasan
Journal:  Angew Chem Int Ed Engl       Date:  2016-11-25       Impact factor: 15.336

5.  Asymmetric Reduction of Activated Alkenes by Pentaerythritol Tetranitrate Reductase: Specificity and Control of Stereochemical Outcome by Reaction Optimisation.

Authors:  Anna Fryszkowska; Helen Toogood; Michiyo Sakuma; John M Gardiner; Gill M Stephens; Nigel S Scrutton
Journal:  Adv Synth Catal       Date:  2009-11       Impact factor: 5.837

6.  A Continuing Career in Biocatalysis: Frances H. Arnold.

Authors:  Rudi Fasan; S B Jennifer Kan; Huimin Zhao
Journal:  ACS Catal       Date:  2019-09-17       Impact factor: 13.084

7.  Stereodivergent Intramolecular Cyclopropanation Enabled by Engineered Carbene Transferases.

Authors:  Ajay L Chandgude; Xinkun Ren; Rudi Fasan
Journal:  J Am Chem Soc       Date:  2019-05-29       Impact factor: 15.419

8.  Combining a Clostridial enzyme exhibiting unusual active site plasticity with a remarkably facile sigmatropic rearrangement: rapid, stereocontrolled entry into densely functionalized fluorinated phosphonates for chemical biology.

Authors:  Kaushik Panigrahi; Gregory A Applegate; Guillaume Malik; David B Berkowitz
Journal:  J Am Chem Soc       Date:  2015-03-05       Impact factor: 15.419

9.  Biotinylated Rh(III) complexes in engineered streptavidin for accelerated asymmetric C-H activation.

Authors:  Todd K Hyster; Livia Knörr; Thomas R Ward; Tomislav Rovis
Journal:  Science       Date:  2012-10-26       Impact factor: 47.728

10.  Hydroxynitrile lyases with α/β-hydrolase fold: two enzymes with almost identical 3D structures but opposite enantioselectivities and different reaction mechanisms.

Authors:  Jennifer N Andexer; Nicole Staunig; Thorsten Eggert; Christoph Kratky; Martina Pohl; Karl Gruber
Journal:  Chembiochem       Date:  2012-07-31       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.